Medicine
Deferiprone 500 mg tablet
Deferiprone 500 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Deferiprone
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets and 1 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaSun Pharmaceutical IndustriesIndiaAvKAREHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AC02 Deferiprone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 June 2021
- Identifiers
- RxCUI 389242, 2180997DailyMed set ID d7ea0a84-c328-4636-8cd6-ad75f2074b22, 58dd1370-5042-833f-e063-6394a90a0777, 5af1643d-4c6e-4668-ae9b-1046f0ad6d8a +1NDC 0054-0576, 73190-095, 51672-4196 +1Application ANDA213239, ANDA208800, ANDA220132
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, coated in 1 bottle | 75907-349-01 | Dr. Reddy's LaboratoriesIndia | 15 December 2025 |
| 100 tablet in 1 bottle | 51672-4196-1 | Sun Pharmaceutical IndustriesIndia | 5 February 2024 |
| 100 tablet, coated in 1 bottle | 0054-0576-25 | Hikma Pharmaceuticals | 3 June 2021 |
| 100 tablet in 1 bottle | 73190-095-01 | AvKARE | 12 August 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Deferiprone
Clinical summary
Deferiprone is an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes, sickle cell disease or other anemias. MedsAcross supplies Deferiprone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DeferiproneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FERRIPROX prescribing information (Chiesi) · U.S. National Library of Medicine, DailyMed
- Ferriprox: European public assessment report (EPAR) · European Medicines Agency
- Deferiprone Lipomed: European public assessment report (EPAR) · European Medicines Agency
Need Deferiprone 500 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.